| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | 8.38e-06 | 1412 | 27 | 10 | GO:0000981 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1.12e-05 | 1459 | 27 | 10 | GO:0000977 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | 2.31e-05 | 1244 | 27 | 9 | GO:0000978 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | 2.74e-05 | 1271 | 27 | 9 | GO:0000987 | |
| Domain | - | 2.74e-08 | 679 | 28 | 10 | 3.30.160.60 | |
| Domain | zf-C2H2 | 3.32e-08 | 693 | 28 | 10 | PF00096 | |
| Domain | Znf_C2H2/integrase_DNA-bd | 3.37e-08 | 694 | 28 | 10 | IPR013087 | |
| Domain | ZINC_FINGER_C2H2_2 | 9.50e-08 | 775 | 28 | 10 | PS50157 | |
| Domain | ZINC_FINGER_C2H2_1 | 9.73e-08 | 777 | 28 | 10 | PS00028 | |
| Domain | Znf_C2H2-like | 1.22e-07 | 796 | 28 | 10 | IPR015880 | |
| Domain | Znf_C2H2 | 1.35e-07 | 805 | 28 | 10 | IPR007087 | |
| Domain | ZnF_C2H2 | 1.40e-07 | 808 | 28 | 10 | SM00355 | |
| Domain | zf-C2H2_6 | 9.31e-05 | 314 | 28 | 5 | PF13912 | |
| Domain | KRAB | 1.72e-04 | 358 | 28 | 5 | PS50805 | |
| Domain | KRAB | 1.98e-04 | 369 | 28 | 5 | SM00349 | |
| Domain | KRAB | 2.01e-04 | 370 | 28 | 5 | IPR001909 | |
| Domain | KRAB | 1.89e-03 | 358 | 28 | 4 | PF01352 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | ZNF10 AUTS2 ZNF23 ERCC3 ZNF493 KLF4 ZNF382 PLK3 ZNF461 ZNF790 | 6.74e-05 | 1387 | 25 | 10 | M734 |
| Pubmed | 1.02e-07 | 12 | 28 | 3 | 15937668 | ||
| Pubmed | 6.15e-07 | 21 | 28 | 3 | 7865130 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 10802067 | ||
| Pubmed | Mammalian SP/KLF transcription factors: bring in the family. | 1.06e-06 | 25 | 28 | 3 | 15820306 | |
| Pubmed | Deregulated expression of Kruppel-like factors in acute myeloid leukemia. | 3.75e-06 | 4 | 28 | 2 | 21470678 | |
| Pubmed | 6.24e-06 | 5 | 28 | 2 | 25652467 | ||
| Pubmed | Mammalian Krüppel-like transcription factors: more than just a pretty finger. | 1.31e-05 | 7 | 28 | 2 | 10366853 | |
| Pubmed | 1.81e-05 | 709 | 28 | 6 | 22988430 | ||
| Pubmed | 1.85e-05 | 415 | 28 | 5 | 16385451 | ||
| Pubmed | 4.85e-05 | 13 | 28 | 2 | 19850934 | ||
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | 6.71e-05 | 544 | 28 | 5 | 28473536 | |
| Pubmed | Sox2 Acts in Thalamic Neurons to Control the Development of Retina-Thalamus-Cortex Connectivity. | 1.56e-04 | 23 | 28 | 2 | 31082736 | |
| Pubmed | ZNF750 Regulates Skin Barrier Function by Driving Cornified Envelope and Lipid Processing Pathways. | 1.85e-04 | 25 | 28 | 2 | 37660780 | |
| Pubmed | 1.85e-04 | 25 | 28 | 2 | 17130451 | ||
| Pubmed | 2.50e-04 | 29 | 28 | 2 | 39289460 | ||
| Pubmed | Multiple genes encoding zinc finger domains are expressed in human T cells. | 2.86e-04 | 31 | 28 | 2 | 2288909 | |
| Pubmed | Genome-wide association studies in an isolated founder population from the Pacific Island of Kosrae. | 3.45e-04 | 34 | 28 | 2 | 19197348 | |
| Pubmed | 4.21e-04 | 808 | 28 | 5 | 20412781 | ||
| Pubmed | A novel view of the transcriptome revealed from gene trapping in mouse embryonic stem cells. | 4.78e-04 | 40 | 28 | 2 | 17540781 | |
| Pubmed | 6.89e-04 | 48 | 28 | 2 | 27872092 | ||
| Cytoband | 19q13.12 | 1.18e-05 | 72 | 28 | 3 | 19q13.12 | |
| Cytoband | 2q33 | 1.44e-04 | 29 | 28 | 2 | 2q33 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr10p15 | 1.39e-03 | 90 | 28 | 2 | chr10p15 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q33 | 6.95e-03 | 205 | 28 | 2 | chr2q33 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 6.12e-10 | 718 | 19 | 10 | 28 | |
| GeneFamily | Zinc fingers C2H2-type|Kruppel like factors | 7.95e-07 | 18 | 19 | 3 | 624 | |
| Coexpression | NIKOLSKY_BREAST_CANCER_19Q13.1_AMPLICON | 1.48e-06 | 22 | 27 | 3 | M8692 | |
| Coexpression | PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN | 1.14e-05 | 137 | 27 | 4 | M4781 | |
| Coexpression | GSE17974_0H_VS_24H_IN_VITRO_ACT_CD4_TCELL_UP | 4.21e-05 | 191 | 27 | 4 | M4169 | |
| Coexpression | GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_YOUNG_UP | 4.84e-05 | 198 | 27 | 4 | M5293 | |
| Coexpression | GSE22886_DAY0_VS_DAY7_MONOCYTE_IN_CULTURE_UP | 4.93e-05 | 199 | 27 | 4 | M4460 | |
| Coexpression | CHEN_HOXA5_TARGETS_9HR_UP | 7.68e-05 | 223 | 27 | 4 | M17621 | |
| Coexpression | SANSOM_APC_MYC_TARGETS | 1.04e-04 | 241 | 27 | 4 | M1756 | |
| Coexpression | SANSOM_APC_MYC_TARGETS | 1.05e-04 | 242 | 27 | 4 | MM736 | |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | 1.57e-04 | 822 | 27 | 6 | M6782 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.67e-05 | 138 | 27 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_1000 | 6.36e-05 | 836 | 27 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_1000 | 7.07e-05 | 850 | 27 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_top-relative-expression-ranked_1000 | 7.50e-05 | 858 | 27 | 7 | gudmap_dev gonad_e11.5_F_GonMes_Sma_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_SupCellPrec_Sry_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.72e-04 | 223 | 27 | 4 | gudmap_dev gonad_e13.5_F_SupCellPrec_Sry_k2_1000 | |
| ToppCell | droplet-Spleen-nan-18m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.34e-08 | 182 | 28 | 5 | eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.60e-08 | 183 | 28 | 5 | 28cbf909424f3be4491d49832f0aca0386560814 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.60e-08 | 183 | 28 | 5 | 3fa608aa6b119869ec3280dc388dfee57160e63a | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-Trm_Th1/Th17|bone_marrow / Manually curated celltypes from each tissue | 3.18e-06 | 163 | 28 | 4 | 4d1fd0b1246833723b938eca0cb246e937380e12 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.13e-06 | 184 | 28 | 4 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.47e-06 | 187 | 28 | 4 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-Trm_Th1/Th17|lymph-node_spleen / Manually curated celltypes from each tissue | 5.59e-06 | 188 | 28 | 4 | a20521198c6db17589535fb439533329582c9dd2 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-B_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.83e-06 | 190 | 28 | 4 | ee7b60cdf93c695ea2d59a170ca8cf4dc93e7eb2 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-T_follicular_helper_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.07e-06 | 192 | 28 | 4 | 3e2a0f332e7f9833ba88f3c809cee78b65090401 | |
| ToppCell | COVID-19_Mild-CD4+_Tcm|COVID-19_Mild / Disease condition and Cell class | 6.33e-06 | 194 | 28 | 4 | 3be2b1c81e668ffdf593ff41d3ba211c26d77671 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4|GI_small-bowel / Manually curated celltypes from each tissue | 6.33e-06 | 194 | 28 | 4 | 4547b57669be5d4f0de55175802ee04372288a6a | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.46e-06 | 195 | 28 | 4 | 562e4c0e4e81f6303e57b846da71d1667fc35963 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.46e-06 | 195 | 28 | 4 | fa8ac154e5aebc26463ff84f0ad1038095770bc6 | |
| ToppCell | mild_COVID-19|World / disease group, cell group and cell class (v2) | 6.46e-06 | 195 | 28 | 4 | 6dbe9db5f0e94f2e91b3d1282855d200051ab0ba | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-Trm_Th1/Th17|lymph-node_spleen / Manually curated celltypes from each tissue | 6.46e-06 | 195 | 28 | 4 | c60982804a74dbe6607c021799ca74af2204aba8 | |
| ToppCell | (1)_T_cell-(11)_Activated_CD4_T|(1)_T_cell / shred on Cell_type and subtype | 6.86e-06 | 198 | 28 | 4 | 4b9ad91342f622c63e476d4f6a0ae5bf282a7ef5 | |
| ToppCell | Caecum-(1)_T_cell-(12)_Th1|Caecum / shred on region, Cell_type, and subtype | 7.14e-06 | 200 | 28 | 4 | 61328a95966191aec378fa4cd2a083734354b03c | |
| ToppCell | Caecum-T_cell-Th1|Caecum / Region, Cell class and subclass | 7.14e-06 | 200 | 28 | 4 | cfa2e8a6230a8a7b43d2c89fd464cb8b4ca79589 | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Slc17a6|Thalamus / BrainAtlas - Mouse McCarroll V32 | 3.35e-05 | 100 | 28 | 3 | 1de3895e16f14ff32b901b18ce14d965afaa7e76 | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 3.35e-05 | 100 | 28 | 3 | 20675fc2ffc5ab63047d38da083b50d470f3db19 | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Slc17a6-Rora|Thalamus / BrainAtlas - Mouse McCarroll V32 | 3.35e-05 | 100 | 28 | 3 | ff1bdb511700a041a90034d1d30dfc25f51d6c82 | |
| ToppCell | Mild/Remission-B_naive-13|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.01e-04 | 145 | 28 | 3 | 7827aef87f834cd0d19780417757c9386e19b22e | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-CD163+CD14+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 1.10e-04 | 149 | 28 | 3 | a34d095b8e0fe59d69d84e4fd2fe4ccb82f92e4f | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_4|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.12e-04 | 150 | 28 | 3 | c843bcf98c5fad2ca4339602f721f3fb782ae353 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Neural-neural_cell-Schwann_Cell_/_Neural-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-04 | 154 | 28 | 3 | 30cb4bb297fa815adb829f3b5cafca56fcbcb810 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Neural-neural_cell-Schwann_Cell_/_Neural|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-04 | 154 | 28 | 3 | ade094e2947761a0a34daa8fcff3e9ea8437e4a5 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Neural|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-04 | 154 | 28 | 3 | 42bd8f88fd075a2d4edde394785decad88a2660a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Neural-neural_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-04 | 154 | 28 | 3 | 6425d9861148586466febd6eceae1b1f9b9a14c1 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMK+-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.41e-04 | 162 | 28 | 3 | 19395bdb282b4a2d88cd33191af12c24a88c3d16 | |
| ToppCell | 10x5'v1-week_17-19-Hematopoietic-HSC/MPP_and_pro-ELP|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.62e-04 | 170 | 28 | 3 | a50e558d0b38100ccbdccb90647fe93e85bffd86 | |
| ToppCell | 368C-Lymphocytic-ILC|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.65e-04 | 171 | 28 | 3 | 3b3143e4aa6520ee9c6b6f2482206ad3d8205d14 | |
| ToppCell | 368C-Lymphocytic-ILC-ILC-2|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.65e-04 | 171 | 28 | 3 | fd01076574dcc82bfd4a1538812500543b16794f | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.5.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.65e-04 | 171 | 28 | 3 | 5e93c76ee60f9d0590ebb140812653a5e1369417 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.76e-04 | 175 | 28 | 3 | 6374ab186d7ccf7f6dfb858267edba8962789e15 | |
| ToppCell | (03)_Secretory-(4)_1wkpi|(03)_Secretory / shred by cell type and Timepoint | 1.76e-04 | 175 | 28 | 3 | 06b52f85baa31b55bb31477244892b6da79fe2c9 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like-MAIT|lymph-node_spleen / Manually curated celltypes from each tissue | 1.79e-04 | 176 | 28 | 3 | 25c197d3b39deffa4801a1d12cdb54320cbae509 | |
| ToppCell | droplet-Large_Intestine-COLON_-_"PROM_Tm"-30m-Epithelial-Enterocyte|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-04 | 176 | 28 | 3 | ce950805aaa3d39630376028ecd7da584fdb4394 | |
| ToppCell | droplet-Large_Intestine-COLON_-_"PROM_Tm"-30m-Epithelial-enterocyte_of_epithelium_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-04 | 176 | 28 | 3 | 5b65693833e02c08530488cbe37883e7c75f312e | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-04 | 179 | 28 | 3 | fca111789d7354de7ae4cd38253aa0685c0cb2d2 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c08-GZMK-FOS_h|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.89e-04 | 179 | 28 | 3 | b0585a8e596c3d8e434af943e65207fa5877600d | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-04 | 179 | 28 | 3 | c3e53a3b8e59f7245d737386a1dd0f9d7aa5fb61 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-04 | 182 | 28 | 3 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Macroglial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-04 | 184 | 28 | 3 | da8d6e7944eb35e6cbea2feb7cbc2894787d723f | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Macroglial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-04 | 184 | 28 | 3 | a7399a72f065d68800e3e0b2031d9894e0cc0ba4 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-04 | 185 | 28 | 3 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | PBMC-Mild-cDC_8|Mild / Compartment, Disease Groups and Clusters | 2.08e-04 | 185 | 28 | 3 | 891b39c20fe9858fbba90d9ef7a253f1a0870211 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.18e-04 | 188 | 28 | 3 | 0da6d6d3c28e9d99159b1a24a345a2250e8e1995 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.18e-04 | 188 | 28 | 3 | 5e13725136114e42d3b59647cf25e0f3c53abb54 | |
| ToppCell | 3'_v3-GI_small-bowel|World / Manually curated celltypes from each tissue | 2.18e-04 | 188 | 28 | 3 | 822c6abaf7bcd6721269bdbd1f2b286ccf0aec1a | |
| ToppCell | (1)_T_CD4|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.21e-04 | 189 | 28 | 3 | 2298a96c53c5bd767e17554c50379b2d1ad8b5b0 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD8-Trm/em_CD8|bone_marrow / Manually curated celltypes from each tissue | 2.21e-04 | 189 | 28 | 3 | 17733be6ead1d24149d478023f731d23876b4f54 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Macroglial-Schwann_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-04 | 190 | 28 | 3 | ff3dec5b45c6ea9b5319fb51a0198c6773b7be26 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Epithelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-04 | 190 | 28 | 3 | 92456f6f7eced6e4c4371f495254a65d061c8d0b | |
| ToppCell | COPD-Lymphoid-T_Cytotoxic|Lymphoid / Disease state, Lineage and Cell class | 2.25e-04 | 190 | 28 | 3 | 10bece40d980d37a01dae8ce887655bf9f93040c | |
| ToppCell | T_cells-Effector_memory_CD4+_T_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 2.25e-04 | 190 | 28 | 3 | 1af91fe0ee2c924e12f4db93c793e7af475d8f80 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Macroglial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-04 | 190 | 28 | 3 | 4971857eac9af17d66d673ed2ab7072639f60a10 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-04 | 191 | 28 | 3 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.28e-04 | 191 | 28 | 3 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_macrophage-stroma-monocytoid_macrophage|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.28e-04 | 191 | 28 | 3 | 8a67dc87c926c826a09cf6469c8ebf90c80b06db | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-04 | 191 | 28 | 3 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-04 | 191 | 28 | 3 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 2.32e-04 | 192 | 28 | 3 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_I-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.35e-04 | 193 | 28 | 3 | 26a55e98005163122d277480d1d44dd6910ab42f | |
| ToppCell | (1)_T_cells-(1)_T_CD4|(1)_T_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.35e-04 | 193 | 28 | 3 | 788daf1d7c7a26eb052b386a114248772e05c27e | |
| ToppCell | Control-B_naive-13|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.35e-04 | 193 | 28 | 3 | 2c1fce66ad688f2ec0278fc86afaa1bf107bb9f4 | |
| ToppCell | Control-B_naive-13|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.35e-04 | 193 | 28 | 3 | 32e53a6473a682cf14b20a399c3686f658298b93 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-Tfh|lymph-node_spleen / Manually curated celltypes from each tissue | 2.35e-04 | 193 | 28 | 3 | dea7d0b2eadff01e0e169c6916dea04253521d48 | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4-Teffector/EM_CD4|blood / Manually curated celltypes from each tissue | 2.39e-04 | 194 | 28 | 3 | 8499c03fa3d5cf9631b128681b13b7fc512b7e63 | |
| ToppCell | ILEUM-inflamed-(1)_Trm|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.39e-04 | 194 | 28 | 3 | cf22bd6afe51c42cb151c37a8b65c98649dae1a4 | |
| ToppCell | Severe-CD4+_T|World / Disease group and Cell class | 2.39e-04 | 194 | 28 | 3 | 2ad888f78765ecfb8d1ea978c75c90fa3030509a | |
| ToppCell | normal_Lymph_Node-T/NK_cells-CD4+_Th|normal_Lymph_Node / Location, Cell class and cell subclass | 2.39e-04 | 194 | 28 | 3 | 208b56b2a1f5494b74f9423f2bdc2eb6d6023fa9 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.39e-04 | 194 | 28 | 3 | 76c4c3ba5f1bcc39d397c90db3513f5bea632b1b | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes-Non-classical_monocytes_L.1.2.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.39e-04 | 194 | 28 | 3 | dfe0ece81922bfd7c6673726d3ea2365cbdb5513 | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.42e-04 | 195 | 28 | 3 | 8b2e29f3b12fcc474abdf3707de96e4613ead1bc | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-Trm_Th1/Th17|Liver / Manually curated celltypes from each tissue | 2.42e-04 | 195 | 28 | 3 | 480cc62ee1e5b1aaf6b62be6e5afd7a81236a1b0 | |
| ToppCell | mild_COVID-19-CD4+_CTL|World / disease group, cell group and cell class (v2) | 2.42e-04 | 195 | 28 | 3 | 980909246c30471c9f2f97c3b20b6d6d20fe574e | |
| ToppCell | metastatic_Lymph_Node-T/NK_cells-CD4+_Th|T/NK_cells / Location, Cell class and cell subclass | 2.42e-04 | 195 | 28 | 3 | 944158240cfc3b2cf72a6601b4e02d8d31a903b9 | |
| ToppCell | PBMC-Control-cDC_7|Control / Compartment, Disease Groups and Clusters | 2.42e-04 | 195 | 28 | 3 | c8f9f2911c2f963b5d1336fbb5567bfc7f3e737b | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD8|GI_small-bowel / Manually curated celltypes from each tissue | 2.46e-04 | 196 | 28 | 3 | 3f5bf202c5d8c15072255c133793c8ee6e8d932f | |
| ToppCell | lymphoid-T_cell-unlabelled(multiplets)|World / Lineage, cell class and subclass | 2.46e-04 | 196 | 28 | 3 | 78b006922307c154622d71fcbc79ae5eed3f4b23 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD4+_T-CD4+_Tcm-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.46e-04 | 196 | 28 | 3 | d4fd5513e98eec092d51199e7f054bc15a5eaa3d | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD4+_T-CD4+_Tcm-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.46e-04 | 196 | 28 | 3 | 3a08209210e1a8677097a78786e00062c81b1ad2 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD4+_T-CD4+_Tcm|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.46e-04 | 196 | 28 | 3 | fddc3e89e7e6b093563655c2d02e86836cfd6da5 | |
| ToppCell | IPF-Lymphoid-T|Lymphoid / Disease state, Lineage and Cell class | 2.46e-04 | 196 | 28 | 3 | 6e70c48a63d9673eb16b0847c1bd88eecc2f7a3c | |
| ToppCell | COVID-19_Convalescent-CD4+_Tcm|COVID-19_Convalescent / Disease condition and Cell class | 2.46e-04 | 196 | 28 | 3 | f2a5eeb1cebde2762865ab29792370b751214c4d | |
| ToppCell | COVID-19_Severe-Neu_0|COVID-19_Severe / 5 Neutrophil clusters in COVID-19 patients | 2.46e-04 | 196 | 28 | 3 | 4831243fcd680cf4821fa0246e758c3e7c13a962 | |
| ToppCell | Control-B_naive-8|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.46e-04 | 196 | 28 | 3 | 54074da84000e4749ade8acc542f05a275bf829f | |
| ToppCell | Severe-CD4+_T|Severe / Disease group and Cell class | 2.46e-04 | 196 | 28 | 3 | 576e0aa2ae146a86201dea21097ffe1c867956e7 | |
| ToppCell | (2)_NK/T-(231)_CD4+/CD45RO+_Memory_T_cell|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization) | 2.46e-04 | 196 | 28 | 3 | 5267acead12207f238d9afa3eef8ac1168b47082 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.46e-04 | 196 | 28 | 3 | 5fe6534af65d43eeacd4b031310242b4f706008b | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD8-Trm_gut_CD8|GI_small-bowel / Manually curated celltypes from each tissue | 2.46e-04 | 196 | 28 | 3 | 528622874692d7d65c905738b078ab53acef5846 | |
| ToppCell | COVID-19-Lymphoid-CD4_T_cells|Lymphoid / Condition, Lineage and Cell class | 2.46e-04 | 196 | 28 | 3 | 28515d8e2f02366fa0ac1bea251a7a3f659c98c7 | |
| ToppCell | COPD-Lymphoid-T|Lymphoid / Disease state, Lineage and Cell class | 2.46e-04 | 196 | 28 | 3 | c9bdd505c3ab380ed7b272aa518df31a0a706a06 | |
| ToppCell | COVID-19_Severe-Neu_0|World / 5 Neutrophil clusters in COVID-19 patients | 2.46e-04 | 196 | 28 | 3 | 4fdea41ac7d84f0c52d102d87a5fce620480985e | |
| ToppCell | COVID-19_Convalescent-Lymphoid_T/NK-CD4+_Tcm|COVID-19_Convalescent / Disease group, lineage and cell class | 2.46e-04 | 196 | 28 | 3 | 8caf4334ae692ce44e8fea5d606416afc5b72c00 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD4+_T-CD4+_Tcm|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.46e-04 | 196 | 28 | 3 | 7d841113a7161b017a08602d46366ac044271b34 | |
| ToppCell | normal_Lung-T/NK_cells-CD4+_Th|T/NK_cells / Location, Cell class and cell subclass | 2.50e-04 | 197 | 28 | 3 | 80b3902ceea242148a1f1707c633f66afedf5183 | |
| ToppCell | tumor_Lung-T/NK_cells-CD4+_Th|T/NK_cells / Location, Cell class and cell subclass | 2.50e-04 | 197 | 28 | 3 | 0379d67beeba5864b5ffe5d282643204a112754f | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-PFC|World / Primary Cells by Cluster | 2.50e-04 | 197 | 28 | 3 | 2c3b0072f8e1e09c77a85c6fc3133d1796932fb2 | |
| ToppCell | lymphoid-T_cell-unlabelled(multiplets)|lymphoid / Lineage, cell class and subclass | 2.50e-04 | 197 | 28 | 3 | a224c0a010489ad043bd2ad1385eef33c3b6b792 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 4.14e-05 | 50 | 15 | 3 | GAVISH_3CA_METAPROGRAM_MACROPHAGES_STRESS_HSP | |
| Drug | 16-phenyl tetranor Prostaglandin E2; Down 200; 10uM; MCF7; HT_HG-U133A | 7.99e-08 | 198 | 26 | 6 | 7505_DN | |
| Drug | Mefloquine hydrochloride [51773-92-3]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 9.40e-07 | 160 | 26 | 5 | 2210_UP | |
| Drug | Primaquine diphosphate [63-45-6]; Up 200; 8.8uM; MCF7; HT_HG-U133A | 1.68e-06 | 180 | 26 | 5 | 3279_UP | |
| Drug | Anisomycin [22862-76-6]; Up 200; 15uM; MCF7; HT_HG-U133A | 3.11e-05 | 160 | 26 | 4 | 5364_UP | |
| Drug | Prenylamine lactate [69-43-2]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 3.19e-05 | 161 | 26 | 4 | 2886_UP | |
| Drug | Perhexiline maleate [6724-53-4]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 3.94e-05 | 170 | 26 | 4 | 5501_UP | |
| Drug | felodipine; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 3.94e-05 | 170 | 26 | 4 | 965_UP | |
| Drug | cytochalasin B; Up 200; 20.8uM; MCF7; HT_HG-U133A_EA | 4.22e-05 | 173 | 26 | 4 | 1122_UP | |
| Drug | Emetine dihydrochloride [316-42-7]; Up 200; 7.2uM; PC3; HT_HG-U133A | 4.32e-05 | 174 | 26 | 4 | 4243_UP | |
| Drug | Ciclopirox ethanolamine [41621-49-2]; Up 200; 15uM; HL60; HT_HG-U133A | 4.32e-05 | 174 | 26 | 4 | 2456_UP | |
| Drug | Cephaeline dihydrochloride heptahydrate [6487-30-5]; Up 200; 6uM; PC3; HT_HG-U133A | 4.42e-05 | 175 | 26 | 4 | 4651_UP | |
| Drug | Nifuroxazide [965-52-6]; Up 200; 14.6uM; MCF7; HT_HG-U133A | 4.72e-05 | 178 | 26 | 4 | 2850_UP | |
| Drug | Prenylamine lactate [69-43-2]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 4.82e-05 | 179 | 26 | 4 | 5489_UP | |
| Drug | Menadione [58-27-5]; Up 200; 23.2uM; PC3; HT_HG-U133A | 5.04e-05 | 181 | 26 | 4 | 4662_UP | |
| Drug | LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 5.37e-05 | 184 | 26 | 4 | 1007_UP | |
| Drug | LY 294002; Up 200; 10uM; HL60; HT_HG-U133A | 6.60e-05 | 194 | 26 | 4 | 1180_UP | |
| Drug | Doxazosin mesylate [77883-43-3]; Down 200; 7.4uM; PC3; HT_HG-U133A | 6.60e-05 | 194 | 26 | 4 | 6642_DN | |
| Drug | Dydrogesterone [152-62-5]; Down 200; 12.8uM; HL60; HT_HG-U133A | 6.73e-05 | 195 | 26 | 4 | 2156_DN | |
| Drug | Phenazopyridine hydrochloride [136-40-3]; Up 200; 16uM; PC3; HT_HG-U133A | 6.86e-05 | 196 | 26 | 4 | 5758_UP | |
| Drug | Terconazole [67915-31-5]; Up 200; 7.6uM; HL60; HT_HG-U133A | 6.86e-05 | 196 | 26 | 4 | 2484_UP | |
| Drug | CP-863187 [668981-07-5]; Down 200; 10uM; MCF7; HT_HG-U133A | 7.14e-05 | 198 | 26 | 4 | 7508_DN | |
| Drug | Dubinidine [22964-77-8]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 7.14e-05 | 198 | 26 | 4 | 3554_DN | |
| Drug | Tribenoside [10310-32-4]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 7.14e-05 | 198 | 26 | 4 | 5429_UP | |
| Drug | Fosfosal [6064-83-1]; Up 200; 18.4uM; MCF7; HT_HG-U133A | 7.28e-05 | 199 | 26 | 4 | 4823_UP | |
| Drug | Succinylsulfathiazole [116-43-8]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 7.28e-05 | 199 | 26 | 4 | 4847_UP | |
| Drug | PF-00875133-00 [351322-64-0]; Up 200; 10uM; PC3; HT_HG-U133A | 7.28e-05 | 199 | 26 | 4 | 5928_UP | |
| Drug | 2-propylpentanoic acid; Down 200; 1000uM; HL60; HT_HG-U133A | 7.28e-05 | 199 | 26 | 4 | 6168_DN | |
| Drug | 1-methylanthracene | 9.36e-05 | 677 | 26 | 6 | ctd:C051246 | |
| Drug | PCI 5002 | 1.47e-04 | 735 | 26 | 6 | ctd:C568608 | |
| Drug | vinylene | 1.62e-04 | 245 | 26 | 4 | CID000006326 | |
| Drug | AC1LCVTP | 3.23e-04 | 118 | 26 | 3 | CID000656983 | |
| Drug | fluoranthene | 3.25e-04 | 851 | 26 | 6 | ctd:C007738 | |
| Drug | carbonyl sulfide | 4.69e-04 | 134 | 26 | 3 | ctd:C010063 | |
| Drug | Lycorine hydrochloride [2188-68-3]; Up 200; 12.4uM; PC3; HT_HG-U133A | 6.91e-04 | 153 | 26 | 3 | 3808_UP | |
| Drug | Azacyclonol [115-46-8]; Up 200; 15uM; MCF7; HT_HG-U133A | 7.04e-04 | 154 | 26 | 3 | 1520_UP | |
| Drug | thioridazine hydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 7.31e-04 | 156 | 26 | 3 | 1010_UP | |
| Drug | Niclosamide [50-65-7]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 7.58e-04 | 158 | 26 | 3 | 4136_UP | |
| Drug | Methyl benzethonium chloride [25155-18-4]; Up 200; 8.6uM; PC3; HT_HG-U133A | 7.72e-04 | 159 | 26 | 3 | 4325_UP | |
| Drug | Lanatoside C [17575-22-3]; Up 200; 4uM; PC3; HT_HG-U133A | 7.72e-04 | 159 | 26 | 3 | 4328_UP | |
| Drug | Pyrvinium pamoate [3546-41-6]; Up 200; 3.4uM; MCF7; HT_HG-U133A | 8.01e-04 | 161 | 26 | 3 | 5439_UP | |
| Drug | Thioridazine hydrochloride [130-61-0]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 8.15e-04 | 162 | 26 | 3 | 1486_UP | |
| Drug | Lanatoside C [17575-22-3]; Up 200; 4uM; MCF7; HT_HG-U133A | 8.45e-04 | 164 | 26 | 3 | 3963_UP | |
| Drug | Helveticoside [630-64-8]; Up 200; 7.4uM; PC3; HT_HG-U133A | 8.75e-04 | 166 | 26 | 3 | 4327_UP | |
| Drug | Strophanthidin [66-28-4]; Up 200; 9.8uM; PC3; HT_HG-U133A | 8.75e-04 | 166 | 26 | 3 | 5826_UP | |
| Drug | Digoxin [20830-75-5]; Up 200; 5.2uM; MCF7; HT_HG-U133A | 8.75e-04 | 166 | 26 | 3 | 5324_UP | |
| Drug | Digitoxigenin [143-62-4]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 8.90e-04 | 167 | 26 | 3 | 4801_UP | |
| Drug | Clorgyline | 9.06e-04 | 168 | 26 | 3 | ctd:D003010 | |
| Drug | Digoxin [20830-75-5]; Up 200; 5.2uM; PC3; HT_HG-U133A | 9.21e-04 | 169 | 26 | 3 | 6724_UP | |
| Drug | Thonzonium bromide [553-08-2]; Up 200; 6.8uM; PC3; HT_HG-U133A | 9.86e-04 | 173 | 26 | 3 | 4617_UP | |
| Drug | Phenoxybenzamine hydrochloride [63-92-3]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 1.00e-03 | 174 | 26 | 3 | 5248_UP | |
| Drug | 17-AAG; Up 200; 1uM; HL60; HT_HG-U133A | 1.05e-03 | 177 | 26 | 3 | 2678_UP | |
| Drug | thioridazine hydrochloride; Up 200; 10uM; PC3; HT_HG-U133A | 1.05e-03 | 177 | 26 | 3 | 1230_UP | |
| Drug | Fluspirilen [1841-19-6]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 1.05e-03 | 177 | 26 | 3 | 6463_UP | |
| Drug | lomustine; Up 200; 100uM; PC3; HT_HG-U133A | 1.07e-03 | 178 | 26 | 3 | 7094_UP | |
| Drug | 0175029-0000 [211245-78-2]; Up 200; 1uM; MCF7; HT_HG-U133A | 1.07e-03 | 178 | 26 | 3 | 4716_UP | |
| Drug | Piperlongumine [20069-09-4]; Up 200; 12.6uM; MCF7; HT_HG-U133A | 1.07e-03 | 178 | 26 | 3 | 2757_UP | |
| Drug | Strophantine octahydrate [11018-89-6]; Up 200; 5.4uM; MCF7; HT_HG-U133A | 1.09e-03 | 179 | 26 | 3 | 2656_UP | |
| Drug | AC1L1IPV | 1.10e-03 | 43 | 26 | 2 | CID000004683 | |
| Drug | Mebendazole [31431-39-7]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 1.11e-03 | 180 | 26 | 3 | 4694_UP | |
| Drug | H-7 dihydrochloride; Down 200; 100uM; MCF7; HT_HG-U133A | 1.12e-03 | 181 | 26 | 3 | 5963_DN | |
| Drug | prochlorperazine dimaleate salt; Up 200; 10uM; HL60; HT_HG-U133A | 1.12e-03 | 181 | 26 | 3 | 2675_UP | |
| Drug | STOCK1N-35215; Up 200; 10uM; PC3; HT_HG-U133A | 1.14e-03 | 182 | 26 | 3 | 6427_UP | |
| Drug | radicicol, diheterospora chlamydosporia; Up 200; 0.1uM; HL60; HT_HG-U133A | 1.14e-03 | 182 | 26 | 3 | 1160_UP | |
| Drug | Rimexolone [49697-38-3]; Down 200; 10.8uM; HL60; HT_HG-U133A | 1.18e-03 | 184 | 26 | 3 | 2955_DN | |
| Drug | Mitoxantrone dihydrochloride [70476-82-3]; Down 200; 7.8uM; PC3; HT_HG-U133A | 1.18e-03 | 184 | 26 | 3 | 6755_DN | |
| Drug | Fluoxetine hydrochloride [59333-67-4]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 1.18e-03 | 184 | 26 | 3 | 5356_UP | |
| Drug | 0175029-0000 [211245-78-2]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.18e-03 | 184 | 26 | 3 | 4713_DN | |
| Drug | Cyproheptadine hydrochloride [969-33-5]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 1.18e-03 | 184 | 26 | 3 | 5340_UP | |
| Drug | retinoic acid; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 1.20e-03 | 185 | 26 | 3 | 1049_DN | |
| Drug | Lasalocid sodium salt [25999-20-6]; Up 200; 6.6uM; PC3; HT_HG-U133A | 1.20e-03 | 185 | 26 | 3 | 6639_UP | |
| Drug | retinoic acid; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 1.21e-03 | 186 | 26 | 3 | 966_DN | |
| Drug | Cloperastine hydrochloride [14984-68-0]; Up 200; 11uM; PC3; HT_HG-U133A | 1.21e-03 | 186 | 26 | 3 | 4271_UP | |
| Drug | 0175029-0000 [211245-78-2]; Down 200; 10uM; PC3; HT_HG-U133A | 1.21e-03 | 186 | 26 | 3 | 6875_DN | |
| Drug | Myricetin [529-44-2]; Up 200; 12.6uM; HL60; HT_HG-U133A | 1.21e-03 | 186 | 26 | 3 | 1334_UP | |
| Drug | Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A | 1.23e-03 | 187 | 26 | 3 | 5204_UP | |
| Drug | Alsterpaullone; Down 200; 10uM; MCF7; HT_HG-U133A | 1.23e-03 | 187 | 26 | 3 | 7051_DN | |
| Drug | Clotrimazole [23593-75-1]; Up 200; 11.6uM; PC3; HT_HG-U133A | 1.23e-03 | 187 | 26 | 3 | 5726_UP | |
| Drug | Methotrexate [59-05-2]; Up 200; 8.8uM; MCF7; HT_HG-U133A | 1.23e-03 | 187 | 26 | 3 | 5419_UP | |
| Drug | Nocodazole [31430-18-9]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 1.25e-03 | 188 | 26 | 3 | 2239_UP | |
| Drug | Alsterpaullone; Down 200; 10uM; PC3; HT_HG-U133A | 1.25e-03 | 188 | 26 | 3 | 7078_DN | |
| Drug | 0297417-0002B [362658-29-5]; Up 200; 10uM; PC3; HT_HG-U133A | 1.27e-03 | 189 | 26 | 3 | 6895_UP | |
| Drug | Cloperastine hydrochloride [14984-68-0]; Up 200; 11uM; MCF7; HT_HG-U133A | 1.27e-03 | 189 | 26 | 3 | 3408_UP | |
| Drug | H-7 dihydrochloride; Down 200; 100uM; MCF7; HT_HG-U133A | 1.27e-03 | 189 | 26 | 3 | 5936_DN | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 1.27e-03 | 189 | 26 | 3 | 1005_DN | |
| Drug | retinoic acid; Down 200; 1uM; MCF7; HT_HG-U133A | 1.29e-03 | 190 | 26 | 3 | 1636_DN | |
| Drug | Fluvastatin sodium salt [93957-55-2]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 1.31e-03 | 191 | 26 | 3 | 5290_UP | |
| Drug | Dicumarol [66-76-2]; Up 200; 11.8uM; HL60; HT_HG-U133A | 1.33e-03 | 192 | 26 | 3 | 2561_UP | |
| Drug | prazosin hydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 1.33e-03 | 192 | 26 | 3 | 942_DN | |
| Drug | PF-00562151-00 [351320-12-2]; Down 200; 10uM; PC3; HT_HG-U133A | 1.33e-03 | 192 | 26 | 3 | 5959_DN | |
| Drug | rosiglitazone; Up 200; 10uM; HL60; HT_HG-U133A | 1.33e-03 | 192 | 26 | 3 | 1174_UP | |
| Drug | 0179445-0000 [211246-22-9]; Up 200; 10uM; PC3; HT_HG-U133A | 1.35e-03 | 193 | 26 | 3 | 4289_UP | |
| Drug | Dilazep dihydrochloride [20153-98-4]; Down 200; 6uM; MCF7; HT_HG-U133A | 1.35e-03 | 193 | 26 | 3 | 2294_DN | |
| Drug | Thiamphenicol [15318-45-3]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 1.35e-03 | 193 | 26 | 3 | 7033_DN | |
| Drug | Progesterone [57-83-0]; Down 200; 12.8uM; PC3; HT_HG-U133A | 1.35e-03 | 193 | 26 | 3 | 6646_DN | |
| Drug | oxaprozin; Up 200; 300uM; MCF7; HT_HG-U133A_EA | 1.35e-03 | 193 | 26 | 3 | 971_UP | |
| Disease | microcephaly (implicated_via_orthology) | 3.37e-04 | 32 | 25 | 2 | DOID:10907 (implicated_via_orthology) | |
| Disease | aspartate aminotransferase to alanine aminotransferase ratio | 1.06e-03 | 239 | 25 | 3 | EFO_0010934 | |
| Disease | bipolar disorder | 1.32e-03 | 577 | 25 | 4 | MONDO_0004985 | |
| Disease | Antihypertensive use measurement | 1.42e-03 | 265 | 25 | 3 | EFO_0009927 | |
| Disease | Agents acting on the renin-angiotensin system use measurement | 2.77e-03 | 335 | 25 | 3 | EFO_0009931 | |
| Disease | brain connectivity measurement | 4.56e-03 | 400 | 25 | 3 | EFO_0005210 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 6.20e-03 | 447 | 25 | 3 | EFO_0000694, MONDO_0100096 | |
| Disease | smoking status measurement, systolic blood pressure | 7.69e-03 | 156 | 25 | 2 | EFO_0006335, EFO_0006527 | |
| Disease | body fat percentage | 7.89e-03 | 488 | 25 | 3 | EFO_0007800 | |
| Disease | mean arterial pressure | 8.39e-03 | 499 | 25 | 3 | EFO_0006340 | |
| Disease | mortality | 9.38e-03 | 173 | 25 | 2 | EFO_0004352 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TYKKHRSSHAHTNNF | 311 | O75077 | |
| TKKHHTSSVYSISER | 506 | Q6XZF7 | |
| KKSQHRSSSSAPHHN | 526 | Q08289 | |
| SSYKSKHRIHHSTSH | 111 | P49759 | |
| HSPYEITTDLHSSKH | 496 | Q9NS39 | |
| YTKSSHLKAHLRTHT | 441 | O43474 | |
| YTKSSHLKAHRRTHT | 271 | P57682 | |
| HTPVEKRKYNPTSHH | 141 | Q9NXR8 | |
| KRKYNPTSHHTTTDH | 146 | Q9NXR8 | |
| HSKKSRLSHPHHYSS | 136 | Q8WXX7 | |
| YTKTGSAPHLTHHTL | 36 | Q9H974 | |
| THRSHPGKTNKATTY | 816 | Q9H7U1 | |
| PSHKYSAHSSHVTNV | 826 | Q9HC35 | |
| YHSSRSKAPSKHVHP | 761 | P19447 | |
| KTSKKHHSDTVHYGQ | 646 | Q68DL7 | |
| YGHKTTHHTTERPSA | 661 | Q9H5Y7 | |
| HTKSKGSFSIQHTYH | 56 | Q02383 | |
| ISKHSKYEHDDRSTH | 661 | Q9BZV3 | |
| RKTVHYNPTSTKHFS | 501 | Q9H4B4 | |
| TRTQNVYHTKKKTHH | 971 | Q15468 | |
| SHLYSHQRTHTGEKP | 446 | P21506 | |
| RKKHSHVHTSDKPYT | 251 | Q8N9L1 | |
| PYGCKKSSHIFSHHS | 561 | Q6PG37 | |
| HRSSHYHTSREDKSP | 496 | Q8N3Z6 | |
| YKESSHLTTHKRIHT | 286 | Q6ZR52 | |
| SSHYITHQTIHSGEK | 236 | P17027 | |
| TLTRHHKTHTGEKAY | 366 | Q96SR6 | |
| SFSHHQRIHSGKKPY | 511 | Q8TAF7 | |
| YTKSSHLKAHQRTHT | 211 | Q99612 |